Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Mar 28, 2005; 11(12): 1854-1858
Published online Mar 28, 2005. doi: 10.3748/wjg.v11.i12.1854
Published online Mar 28, 2005. doi: 10.3748/wjg.v11.i12.1854
Table 2 Biochemical and hematological parameters during IFNα2b with RBV therapy in chronic hepatitis C.
| Time of the treatment | Alanine aminotran-sferase (U/L) | Prothrombin index (%) | Platelets (1×103/mL) | Erythrocytes(1×106/mL) | Leukocytes(1×103/mL) |
| 0 | 106±50 | 95±9.6 | 208±34 | 4.6±0.5 | 6.3±2.1 |
| 16 wk | 24.4±16.7 | 97±6.4 | 198±46 | 4.0±0.5 | 5.1±2.3 |
| 32 wk | 19.6±13.2 | 99±9.2 | 202±63 | 3.9±0.6 | 4.6±1.5 |
| 48 wk | 35±67 | 100±7.4 | 193±62 | 4.1±0.6 | 4.9±1.9 |
- Citation: Anatol P, Robert F, Danuta P. Effect of interferon alpha2b plus ribavirin treatment on selected growth factors in respect to inflammation and fibrosis in chronic hepatitis C. World J Gastroenterol 2005; 11(12): 1854-1858
- URL: https://www.wjgnet.com/1007-9327/full/v11/i12/1854.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i12.1854